{"id":"W2337001617","doi":"10.1007/s10637-016-0351-x","title":"A Phase I study of olaparib and irinotecan in patients with colorectal cancer: Canadian Cancer Trials Group IND 187","year":2016,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Irinotecan; Medicine; Tolerability; Internal medicine; Regimen; Oncology; Neutropenia; PARP inhibitor; Colorectal cancer; Cancer; Chemotherapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003363155,0.0001746368,0.0004792003,0.0003031239,0.00005355698,0.00001140658,0.00007355631,0.00007604884,0.0002848827],"category_scores_gemma":[0.0001463764,0.0001210356,0.00002893542,0.0003471659,0.0002226266,0.0001480951,0.00001413501,0.000121385,0.000002298914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005828143,"about_ca_system_score_gemma":0.002282244,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1690231,"about_ca_topic_score_gemma":0.2089449,"domain_scores_codex":[0.9983245,0.0001289841,0.0005249812,0.0003158844,0.0004660138,0.0002395968],"domain_scores_gemma":[0.99874,0.0001990136,0.0002657674,0.0001352312,0.0001734633,0.0004865628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001613795,0.0008042946,0.9692804,0.00002587221,0.0001780237,0.000006566498,0.003229273,0.00001543185,0.003150508,0.0003103803,0.001539677,0.01984583],"study_design_scores_gemma":[0.0801587,0.003067754,0.9063354,0.0008763774,0.0001160636,0.000002919999,0.0002680258,0.00001483699,0.006486803,0.0008607513,0.001534528,0.000277865],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945475,0.0001696408,0.000006775191,0.003404076,0.0001273692,0.001263995,0.0003568343,0.00001547025,0.0001082645],"genre_scores_gemma":[0.9984556,0.00003392952,0.000174637,0.0007529826,0.0001760105,0.0002560842,0.00003570909,0.00002333085,0.00009169219],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07854491,"threshold_uncertainty_score":0.8365104,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03639334982599422,"score_gpt":0.3302634596488522,"score_spread":0.293870109822858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}